PATENT CLAIM ANALYSIS

Application Number: 15957663
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "186100"]

Abstract:
The present invention relates to the use of an immunogenic composition that comprises a porcine circovirus type 2 (PCV2) antigen for treatment of several clinical manifestations (diseases). Preferably, the clinical manifestations are associated with a PCV2 infection. Preferably, they include lymphadenopathy, lymphoid depletion and/or multinucleated/giant histiocytes. Moreover, the clinical symptoms include lymphadenopathy in combination with one or a multiple of the following symptoms in pigs: (1) interstitial pneumonia with interlobular edema, (2) cutaneous pallor or icterus, (3) mottled atrophic livers, (4) gastric ulcers, (5) nephritis and (6) reproductive disorders, e.g. abortion, stillbirths, mummies, etc. Furthermore the clinical symptoms include Pia like lesions, normally known to be associated with Lawsonia intracellularis infections.

Claim (Index 7):
The method of  claim 1 , wherein said administering of the single dose occurs to pigs exposed to a virulent porcine circovirus type 2 antigen.

Metadata:
- Claim Count in Document: 95.0
- Percentile: 91.0
- Lexical Diversity: 1.65169
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15076381', '14661969', '15249158', '12137141', '12137067']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7870615224126328
- 35 USC 102 Novelty (BERT): 0.6305146655069293
- Combined Prediction Score: 0.7714068367220625
- Mean Citation Score: 586.9136920000002
- Max Citation Score: 627.7997
- Similarity Product: 520.3680409271121

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test